rs2027130

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001365999.1(SZT2):​c.7356A>G​(p.Glu2452Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 1,613,758 control chromosomes in the GnomAD database, including 121,674 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8558 hom., cov: 32)
Exomes 𝑓: 0.38 ( 113116 hom. )

Consequence

SZT2
NM_001365999.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.742

Publications

20 publications found
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 1-43441225-A-G is Benign according to our data. Variant chr1-43441225-A-G is described in ClinVar as Benign. ClinVar VariationId is 260623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.742 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SZT2NM_001365999.1 linkc.7356A>G p.Glu2452Glu synonymous_variant Exon 53 of 72 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkc.7185A>G p.Glu2395Glu synonymous_variant Exon 52 of 71 NP_056099.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkc.7356A>G p.Glu2452Glu synonymous_variant Exon 53 of 72 5 NM_001365999.1 ENSP00000489255.1
SZT2ENST00000562955.2 linkc.7185A>G p.Glu2395Glu synonymous_variant Exon 52 of 71 5 ENSP00000457168.1
SZT2ENST00000648058.1 linkn.3810A>G non_coding_transcript_exon_variant Exon 21 of 40
SZT2ENST00000649403.1 linkn.2106A>G non_coding_transcript_exon_variant Exon 18 of 37

Frequencies

GnomAD3 genomes
AF:
0.307
AC:
46734
AN:
152050
Hom.:
8558
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.424
Gnomad AMR
AF:
0.383
Gnomad ASJ
AF:
0.425
Gnomad EAS
AF:
0.0742
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.392
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.407
Gnomad OTH
AF:
0.366
GnomAD2 exomes
AF:
0.324
AC:
81444
AN:
251228
AF XY:
0.324
show subpopulations
Gnomad AFR exome
AF:
0.117
Gnomad AMR exome
AF:
0.324
Gnomad ASJ exome
AF:
0.437
Gnomad EAS exome
AF:
0.0669
Gnomad FIN exome
AF:
0.399
Gnomad NFE exome
AF:
0.415
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
AF:
0.382
AC:
558195
AN:
1461590
Hom.:
113116
Cov.:
51
AF XY:
0.376
AC XY:
273731
AN XY:
727074
show subpopulations
African (AFR)
AF:
0.116
AC:
3879
AN:
33470
American (AMR)
AF:
0.333
AC:
14881
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
11317
AN:
26122
East Asian (EAS)
AF:
0.100
AC:
3985
AN:
39696
South Asian (SAS)
AF:
0.158
AC:
13586
AN:
86246
European-Finnish (FIN)
AF:
0.392
AC:
20955
AN:
53412
Middle Eastern (MID)
AF:
0.398
AC:
2292
AN:
5754
European-Non Finnish (NFE)
AF:
0.419
AC:
465640
AN:
1111802
Other (OTH)
AF:
0.359
AC:
21660
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
18897
37794
56692
75589
94486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13962
27924
41886
55848
69810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.307
AC:
46750
AN:
152168
Hom.:
8558
Cov.:
32
AF XY:
0.304
AC XY:
22609
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.125
AC:
5200
AN:
41530
American (AMR)
AF:
0.383
AC:
5860
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.425
AC:
1473
AN:
3468
East Asian (EAS)
AF:
0.0742
AC:
384
AN:
5176
South Asian (SAS)
AF:
0.147
AC:
710
AN:
4822
European-Finnish (FIN)
AF:
0.392
AC:
4149
AN:
10580
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.407
AC:
27687
AN:
67968
Other (OTH)
AF:
0.364
AC:
770
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1565
3129
4694
6258
7823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
9504
Bravo
AF:
0.302
Asia WGS
AF:
0.128
AC:
444
AN:
3478
EpiCase
AF:
0.418
EpiControl
AF:
0.422

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
10
DANN
Benign
0.60
PhyloP100
0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2027130; hg19: chr1-43906896; COSMIC: COSV65169872; COSMIC: COSV65169872; API